Novavax signs COVID-19 vaccine supply deal with India’s Serum Institute
The deal will foster development and commercialisation of COVID-19 vaccine
The Indian drugmaker will have exclusive rights for the vaccine in India
The experimental vaccine is said to produce high levels of antibodies against COVID-19
